Characterization and compatibility study of desloratadine
Tóm tắt
Desloratadine (DL) is a selective antagonist of the histamine H1 receptor, which has been widely used to treat allergic symptoms, and stands out from other drugs in this therapeutic class because it does not cause sedative effects. In the present study, the physico-chemical properties of DL were fully characterized using six analytical techniques such as Differential Scanning Calorimetry (DSC), Thermogravimetric analysis (TG/DTG), Fourier transform infrared spectroscopy (FT-IR), Raman spectroscopy, Powder X-ray diffraction (PXRD), and scanning electron microscopy (SEM). The DSC curve shows a sharp endothermic event at 158.4 °C, and the TG/DTG curve presents two decomposition events between 178.4 and 451.9 °C. A compatibility study involving DL and nine pharmaceutical excipients generally used in pharmaceutical formulations was performed. Physical binary mixtures of DL with each excipient were prepared in a 1:1 (w/w) ratio. After preparation, the samples were analyzed immediately and the results reveal solid-state interaction with anhydrous lactose, microcrystalline cellulose, magnesium stearate, and stearic acid.
Tài liệu tham khảo
Anthes JC, Gilchrest H, Richard C, Eckel S, Hesk D, West RE Jr, Williams SM, Greenfeder S, Billah M, Kreutner W, Egan RW. Biochemical characterization of desloratadine, a potent antagonist of the human histamine H1 receptor. Eur J Pharm. 2002;449:229–37.
O’Niel MJ, editor. The Merck index: an encyclopedia of chemicals, drugs, and biologicals. 14th ed. New Jersey: Merck; 2006.
Gibson M, editor. Pharmaceutical preformulation and formulation. New York: Informa Helthcare; 2004.
Bernardi LS, Oliveira PR, Murakami FS, Silva MAS, Borgmann SHM, Cardoso SG. Characterization of venlafaxine hydrochloride and compatibility studies with pharmaceutical excipients. J Therm Anal Calorim. 2009;97:729–33.
Stulzer HK, Rodrigues PO, Cardoso TM, Matos JSR, Silva MAS. Compatibility studies between captopril and pharmaceutical excipients used in tablets formulations. J Therm Anal Calorim. 2008;91:323–8.
Jackson K, Young D, Pant S. Drug-excipient interaction and their effect on absorption. Pharm Sci Tech. 2000;3:336–45.
Mura P, Faucci MT, Manderioli A, Bramanti G, Ceccarelli L. Compatibility study between ibuproxam and pharmaceutical excipients using differential scanning calorimetry, hot-stage microscopy and scanning electron microscopy. J Pharm Biomed Anal. 1998;18:151–63.
ICH. Stability testing of new drug substances and products, In: Proceedings of the International Conference on Harmonization. Geneva: IFPMA; 2003.
Tita B, Fulias A, Bandur G, Marian E, Tita D. Compatibility study between ketoprofen and pharmaceutical excipients used in solid dosage forms. J Pharm Biomed Anal. 2011;56:221–7.
Aigner Z, Heinrich R, Sipos E, Farkas G, Ciurba A, Berkesi O, Szabó-Révész P. Compatibility studies of aceclofenac with retard tablet excipients by means of thermal and FT-IR spectroscopic methods. J Therm Anal Calorim. 2010;104:265–71.
Julio TA, Zâmara IF, Garcia JS, Trevisan MG. Compatibility of sildenafil citrate and pharmaceutical excipients by thermal analysis and LC–UV. J Therm Anal Calorim. 2013;111:2037–44.
Oliveira MA, Yoshida MI, Gomes ECL. Análise térmica aplicada a fármacos e formulações farmacêuticas na indústria farmacêutica. Quim Nova. 2011;34:1224–30.
Stephenson GA, Forbes RA, Reutzel-Edens SM. Characterization of the solid state: quantitative issues. Adv Drug Deliv Rev. 2001;48:67–90.
Phadnis NV, Cavatur RK, Suryanarayanan R. Identification of drugs in pharmaceutical dosage forms by X-ray powder diffractometry. J Pharm Biomed Anal. 1997;15:929–43.
Murpani D, Rafeeq M, Raheja P, Sathyanarayana S, Prasad M. Process for the preparation of desloratadine. United States Patent. US 2007/0244144 A1, Oct. 18, 2007.
USP 32: United States Pharmacopeial Convention, 2009. United States Pharmacopeia and National Formulary (USP 32- NF 27). Rockville (MD): United States Pharmacopeial Convention.
Devane MA, Shaikh SR. Formulation and evaluation of desloratadine orodispersible tablets by using ß-cyclodextrin and superdisintegrants. J Pharm Res. 2011;4:3327–30.
Rowe RC, Sheskey PJ, Owen SC. Handbook of pharmaceutical excipients. 5th ed. London: Pharmaceutical Press; 2006.
Monajjemzadeh F, Hassanzadeh D, Valizadeh H, Siahi-Shadbad MR, Mojarrad JS, Robertson TA, Roberts MS. Compatibility studies of acyclovir and lactose in physical mixtures and commercial tablets. Eur J Pharm Biopharm. 2009;73:404–13.
Tita B, Fulias A, Szabadai Z, Rusu G, Bandur G, Tita D. Compatibility study between ibuprofen and excipients in their physical mixtures. J Therm Anal Calorim. 2011;105:517–27.
Roumeli E, Tsiapranta A, Pavlidou E, Vourlias G, Kachrimanis K, Bikiaris D, Chrissafis K. Compatibility study between trandolapril and natural excipients used in solid dosage forms. J Therm Anal Calorim, 2013. doi:10.1007/s10973-012-2476-2.
Cotton ML, Wu DW, Vadas EB. Drug-excipient interaction study of enalapril maleate using thermal analysis and scanning electron microscopy. Int J Pharm. 1987;40:129–42.
Sousa e Silva JP, Sousa Lobo JM. Compatibility studies between nebicapone, a novel COMT inhibitor, and excipients using stepwise isothermal high sensitivity DSC method. J Therm Anal Calorim. 2010;102:317–21.
Tita B, Fulias A, Bandur G, Ledeti I, Tita D. Application of thermal analysis to study the compatibility of sodium diclofenac with different pharmaceutical excipients. Rev Chim. 2011;62:443–54.